FAQs

Frequently Asked Questions (FAQs)

If you have questions about Toxikon's services and capabilities, send us an e-mail. We look forward to hearing from you! Below are some of frequently asked questions.

Q: How are issues of intellectual property handled?

A: Any and all intellectual property is owned by the client/sponsor, and Toxikon works exclusively for, and on behalf of, the client/study sponsor. The research services contract is specific in regards to client/sponsor ownership of results, intellectual property and publication rights.

Q: Can results be published without Toxikon’s authorship?

A: Yes. The results belong to the client/study sponsor and can therefore be published in any form and with any authorship the client/sponsor sees fit. However, Toxikon takes pride in providing more than just results and we would like the opportunity to be involved in all aspects of data reporting and communication. Doing so reflects the strong relationships we build with our clients and sponsors, and that allows them to access to the wealth of thought leadership at Toxikon.

Q: Can you speak on the value of getting in-house generated results validated by an independent party?

A: Before advancing a compound or device to the clinical development stage, many investigators require the reproduction and validation of in-house data by another laboratory. A preclinical CRO, like Toxikon, is positioned to provide an unbiased study based on the original, which can validate existing efficacy data and allow the product to be developed with the confidence that the efficacy data is robust and reliable.

Q: What will a Toxikon study tell me about the overall efficacy of a compound?

A: At Toxikon, we understand how important reliable data is for meeting your goals for IND, NDA and other international submission requirements. That’s why our studies and results will always apply the most applicable statistical analysis so clients and sponsors have the confidence knowing that our scientists understand your application as well as the know-how to navigate the regulatory landscape for you product development path. Sponsors and clients also have the confidence that when a statistical difference is observed, it is reflected in the final report. Our scientists also do their utmost to generate greatest value from any given assay when profiling a compound.

Q: Can models be customized?

A: Any study Toxikon undertakes can be customized. While the routes of administration differ, our scientists understand that every client and/or sponsor has different study needs. Toxikon is positioned to offer sponsor-specific studies, to realize the exact principles of the product and its development.

Don't see what you are looking for? Submit the form below.
/resorce/faqs
harmacology, toxicology, immunotoxicology, pk/tk, preclinical contract research, CRO, biotech